Jay Precision Pharmaceuticals Private Limited
About Jay Precision Pharmaceuticals Private Limited
Data last updated:
Jay Precision Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Cipla Limited. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 01 August 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U33111MH2012PTC234037. Its GSTIN is 27AACCJ8963G1Z7 (Maharashtra).
The company has an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹4.01 Cr. It is led by directors including Xerxes Krishna Rao (Managing Director) and Dinesh Ramniranjan Jain.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Tower A 1st Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013.
As per the financials filed for FY 2025, the company reported a revenue of ₹151.56 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹38.17 Cr (net margin 25.2%) and EBITDA of ₹58.49 Cr (EBITDA margin 38.6%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 8% over five years.
The company has about 438 employees on its provident fund (EPFO) records.
Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 1 case is pending. The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹4 Cr; the latest was in February 2015.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Jay Precision Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressTower A 1st Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Jay Precision Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jay Precision Pharmaceuticals is manufacturing. In detail, this covers plastic products, non-metallic mineral products, rubber products, fabricated metal products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C8 | Plastic products, non-metallic mineral products, rubber products, fabricated metal products |
To see the full business activity and turnover split of Jay Precision Pharmaceuticals Private Limited, buy the company report.
Financials of Jay Precision Pharmaceuticals Private Limited
FY 2025 filings availableJay Precision Pharmaceuticals Private Limited reported revenue of ₹151.56 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹58.49 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹38.17 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 38.6% | ||||
| Net Profit Margin | 25.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jay Precision Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jay Precision Pharmaceuticals Private Limited
Jay Precision Pharmaceuticals has 7 current directors and 20 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Xerxes Krishna Rao Also directs: Konkan Polymers and Additives Private Limited, Metro Metal Printers Pvt Ltd, Xal Engineering (India) Private Limited and 5 more | Managing Director | 01 Aug 2012 | 14 Years 2 Months | Current |
| Dinesh Ramniranjan Jain Also directs: Aspergen Limited, Meditab Specialities Limited, Cipla Pharmaceuticals Limited and 2 more | Director | 01 Apr 2022 | 4 Years 6 Months | Current |
| Zubin Xerxes Rao Also directs: Metro Metal Printers Pvt Ltd, Jay Precision Products (India) Private Limited, Jay Precision Toys (India) Private Limited and 3 more | Director | 02 Jan 2020 | 6 Years 9 Months | Current |
| Chandrashekhar Ramachandran Iyer Also directs: Cipla Health Limited | Director | 10 Sep 2019 | 7 Years 1 Months | Current |
| Achin Gupta | Director | 03 May 2022 | 4 Years 5 Months | Current |
| Amrita Nautiyal Also directs: Gandhar Oil Refinery (India) Limited, Cipla Health Limited, Matix Fertilisers and Chemicals Limited and 5 more | Director | 10 Sep 2019 | 7 Years 1 Months | Current |
Auditor
Jay Precision Pharmaceuticals Private Limited is audited by Sahajwani & Associates LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sahajwani & Associates LLP | FY 2022 | W100690 |
Shareholding
The shareholding of Jay Precision Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Jay Precision Pharmaceuticals Private Limited, buy the company report.
Deals & funding
Jay Precision Pharmaceuticals Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹4 Cr; the latest was in February 2015.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2015 | Secondary share transfer | Undisclosed | Buyer: Cipla Limited & Dinesh Jain, Xal Engineering (India) Private Limited , Cipla Limited & Samina Variralli Seller: 3 individuals |
| Feb 2015 | Funding round | ₹4 Cr | Investors: 3 individuals |
| Nov 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Jay Precision Pharmaceuticals Private Limited has 3 court cases on record: 2 filed by Jay Precision Pharmaceuticals, 1 filed against it. 1 case is pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 1 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Tax appeal | Filed against the company by Chief Commissioner of Income Tax (Osd) | Pending |
| Bombay High Court | Court case (CSD) | Filed by the company | Disposed |
| Bombay High Court | Court case (CSP) | Filed by the company | Disposed |
To see the full case history of Jay Precision Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jay Precision Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Jay Precision Pharmaceuticals Private Limited has a workforce of 438 employees on its EPFO records as of Jun 19, 2024, across 1 active EPFO establishment.
GST
Jay Precision Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCJ8963G1Z7 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Jay Precision Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jay Precision Pharmaceuticals Private Limited has 24 board changes on record since 2012: 7 appointments and 17 cessations. The latest: Prabhakaran Balakrishnan Nair was appointed as Director on 10 Sep 2025.
15 earlier events are in the company report.
Frequently asked questions
Jay Precision Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 01 August 2012 (14+ years old) and is registered under CIN U33111MH2012PTC234037.
Jay Precision Pharmaceuticals has 7 current directors:
- Xerxes Krishna Rao - Managing Director
- Dinesh Ramniranjan Jain - Director
- Zubin Xerxes Rao - Director
- Chandrashekhar Ramachandran Iyer - Director
- Achin Gupta - Director
- Amrita Nautiyal - Director
- Prabhakaran Balakrishnan Nair - Director
The latest financial statements of Jay Precision Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Jay Precision Pharmaceuticals is 27AACCJ8963G1Z7, registered in Maharashtra.
The CIN (Corporate Identification Number) of Jay Precision Pharmaceuticals is U33111MH2012PTC234037. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jay Precision Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it. 1 is pending.
Jay Precision Pharmaceuticals was incorporated on 01 August 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Jay Precision Pharmaceuticals has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹4 Cr; the latest was in February 2015.
Prabhakaran Balakrishnan Nair was appointed as Director on 10 Sep 2025. Rajeev Kumar Sinha ceased to be Additional Director on 08 Sep 2024. Sanjive Baranwal ceased to be CFO on 29 Apr 2024. Jay Precision Pharmaceuticals has 24 board changes on record in total.
The registered office of Jay Precision Pharmaceuticals is at Tower A 1st Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013.